Cell Culturing Pre-Summit Workshop: Overcoming Challenges, Evolving Technologies & Reaching Scale
When: March 15 2023, 13.00– 17.00 PT
Where: IndieBio Headquarters, San Francisco
What: This pre-summit Future Food-Tech workshop will delve deeper into the opportunities and challenges with scaling cell-cultured technologies to reach the shelves. Bringing together innovation leaders, investors, corporate scaling partners and regulators, this workshop will explore the latest developments around growth media & scaffolding technologies, infrastructure for scale, best practices around partnership & regulation to accelerate progress for cell-cultivated products and forge business opportunities.
Book your seat at the workshop when you book your in person ticket at the summit. On the registration page, tick ‘Delegate – In Person’ and the option to add the workshop will pop up. If you have already bought your ticket, fill in the relevant details when prompted to add this onto your summit pass.
COVID-19 Safety Measures: The Workshop venue is currently operating with COVID-19 Safety Measures. All workshop participants are required to show proof of vaccination (including boosters) upon entrance to the venue.
We are working closely with the venue and will update this page with any changes to these measures ahead of the summit and notify registered participants.
- As the cell-based ecosystem continue to evolve will one model succeed over another, or will diversification strengthen the sector holistically?
- End-to-end solutions have dominated the cell-based market, but how are cell-based supply chains evolving with pick-and-shovel models, and what impact does this have?
- What exciting developments have been made with growth media & scaffolding technologies?
- With an increase of hybrid technologies combining cell and plant-based ingredients entering the space, what will the future of the cell based market look like and what exciting new products might emerge?
Speakers:
Romy M. Dalton, COO, COCOON BIOSCIENCE
Kevin Benmoussa, CFO, ALEPH FARMS
Patricia Bubner, CEO & Founder, ORBILLION BIO
- Scaling is CAPEX intensive, and in times of economic instability, what type of partnerships could provide opportunity for innovators to reach scale and proof of concept but at lower cost?
- Partnerships are crucial for progress across the value chain, how can new start-ups create a holistic business strategy to include open innovation and strategic partnerships?
- What role do CDMOs play in partnerships with innovators to enable scale and what is truly required in order to scale? What does successful collaboration look like?
Speaker:
Steve Thomas, Associate Director Applied Science and Industrial Biotechnology, CAMBRIDGE CONSULTANTS
In this session, delegates will break out into groups and work together to discuss potential solutions to a pressing industry problem. Each group will then present their findings at the end.
Host:
Steve Thomas, Associate Director Applied Science and Industrial Biotechnology, CAMBRIDGE CONSULTANTS
- As the market grows, how do new companies find their niche, reach commercialization without market saturation, and how role does IP & patenting play to achieve this?
- How important are IP & patents to establish differentiation between products as more companies reach the point of scale-up, and in turn help to improve consumer messaging and understanding?
- Does intellectual property act as a pathway or roadblock to scale? Does it encourage competition within the alt-protein category, or with the conventional foods intended?
- What precedent does the recent lawsuit with Impossible & Motif set for the food industry and patenting, what are learnings for others in the space and what are the impacts?
Speaker:
Ian Schmertzler, CEO, DISPEL
- With the recent historic approval for cell-cultivated meat in the USA, what does this mean for the future of cell-based foods?
- What impact will approvals have on the challenge of scale – will it be a gateway to funding for high CapEx facilities and scaling activities, or will approvals stall?
- What’s the best practice to achieve regulatory approval? How can innovators best engage with regulators and weave food safety into strategy, in order to reach approval?
- Both Singapore and the US have seen approvals, but what’s happening around the globe? Is there a need for a holistic approach to regulation for cell-based products?
- How do the challenges for the plant-based space in 2022 foreshadow the path of other novel foods, including cell based? What are the drivers around this blip, and how can cell-based prevent this?
- What does this say about consumer adoption of new foods, and what should cell-based focused companies learn from this around the key drivers of nutritional profile, taste, texture & price?
- What role can education, branding & messaging play in consumer adoption? How can innovators communicate the technicality of cell-based foods without alienating the consumer, and overcoming the drive for ‘natural’?
Hosted by: